Dual-targeting exosomes for improved drug delivery in breast cancer.

Tran, Nam Hb et al.·Nanomedicine (London·2023·
RPEP-074732023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Dual-targeting exosomes for improved drug delivery in breast cancer.
Published In:
Nanomedicine (London, England), 18(7), 599-611 (2023)
Database ID:
RPEP-07473

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07473·https://rethinkpeptides.com/research/RPEP-07473

APA

Tran, Nam Hb; Nguyen, Diem Dn; Nguyen, Ngoc Mai; Tran, Chau; Nguyen Thi, Ngoc Thanh; Ho, Duyen Tk; Nguyen, Hoai-Nghia; Tu, Lan N. (2023). Dual-targeting exosomes for improved drug delivery in breast cancer.. Nanomedicine (London, England), 18(7), 599-611. https://doi.org/10.2217/nnm-2022-0328

MLA

Tran, Nam Hb, et al. "Dual-targeting exosomes for improved drug delivery in breast cancer.." Nanomedicine (London, 2023. https://doi.org/10.2217/nnm-2022-0328

RethinkPeptides

RethinkPeptides Research Database. "Dual-targeting exosomes for improved drug delivery in breast..." RPEP-07473. Retrieved from https://rethinkpeptides.com/research/tran-2023-dualtargeting-exosomes-for-improved

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.